Citation: | DING Sheng, LEI Jia-sheng, WANG Dong-dong, ZHAO Guan-ru, MA Shuo-shuo, LU Zheng. Application of nomogram in the prognostic evaluation of patients after intrahepatic cholangiocarcinoma resection[J]. Chinese Journal of General Practice, 2022, 20(7): 1113-1116. doi: 10.16766/j.cnki.issn.1674-4152.002536 |
[1] |
MACIAS R I R, MONTE M J, SERRANO M A, et al. Impact of aging on primary liver cancer: Epidemiology, pathogenesis and therapeutics[J]. Aging (Albany NY), 2021, 13(19): 23416-23434.
|
[2] |
IOFFE D, PHULL P, DOTAN E. Optimal management of patients with advanced or metastatic cholangiocarcinoma: An evidence-based review[J]. Cancer Manag Res, 2021, 13: 8085-8098. doi: 10.2147/CMAR.S276104
|
[3] |
WATANABE Y, MATSUYAMA Y, IZUMI N, et al. Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: A nationwide survey of the Liver Cancer Study Group of Japan[J]. Surgery, 2020, 167: 793-802. doi: 10.1016/j.surg.2019.12.009
|
[4] |
李传涛, 周迟, 崔培元, 等. 术前NLR和PLR与肝门胆管癌根治术后临床病理特征及T分期的关系[J]. 中华全科医学, 2021, 19(7): 1095-1098. doi: 10.16766/j.cnki.issn.1674-4152.001993
LI C T, ZHOU C, CUI P, et al. Preoperative NLR and PLR and radical resection of hilar cholangiocarcinoma Relationship between clinicopathological features and T staging[J]. Chinese Journal of General Practice, 2021, 19(7): 1095-1098. doi: 10.16766/j.cnki.issn.1674-4152.001993
|
[5] |
BAGANTE F, MERATH K, SQUIRES M H, et al. The limitations of standard clinicopathologic features to accurately risk-stratify prognosis after resection of intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg, 2018, 22(3): 477-485. doi: 10.1007/s11605-018-3682-4
|
[6] |
MATSUDA T, UMEDA Y, MATSUDA T, et al. Preoperative prognostic nutritional index predicts postoperative infectious complications and oncological outcomes after hepatectomy in intrahepatic cholangiocarcinoma[J]. BMC Cancer, 2021, 21(1): 1-12. doi: 10.1186/s12885-020-07763-8
|
[7] |
FU J, CHEN Q J J, YU Y Y, et al. Impact of portal hypertension on short-and long-term outcomes after liver resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis[J]. Cancer Med, 2021, 10(20): 6985-6997. doi: 10.1002/cam4.4222
|
[8] |
SIM J H, KIM S H, JUN I G, et al. The association between prognostic nutritional index (PNI) and intraoperative transfusion in patients undergoing hepatectomy for hepatocellular carcinoma: A Retrospective cohort study[J]. Cancers (Basel), 2021, 13(11): 2508. doi: 10.3390/cancers13112508
|
[9] |
ITOH S, TSUJITA E, FUKUZAWA K, et al. Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: A multi-institutional retrospective study[J]. Pancreatology, 2021, 21(7): 1356-1363. doi: 10.1016/j.pan.2021.08.003
|
[10] |
MORO A, MEHTA R, SAHARA K, et al. The impact of preoperative CA19-9 and CEA on outcomes of patients with intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2020, 27(8): 2888-2901. doi: 10.1245/s10434-020-08350-8
|
[11] |
ZHANG X Y, ZHOU Y J, WU Z R, et al. Double-negative α-fetoprotein and carbohydrate antigen 19-9 predict a good prognosis in intrahepatic cholangiocarcinoma: A propensity score matching analysis[J]. Clin Transl Gastroenterol, 2021, 12(11): e00425. DOI: 10.14309/ctg.0000000000000425.
|
[12] |
BUETTNER S, TEN CATE D W G, BAGANTE F, et al. Survival after resection of multiple tumor foci of intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg, 2019, 23(11): 2239-2246. doi: 10.1007/s11605-019-04184-2
|
[13] |
OKUBO S, MITSUNAGA S, KATO Y, et al. The prognostic impact of differentiation at the invasive front of biliary tract cancer[J]. J Surg Oncol, 2018, 117: 1278-1287. doi: 10.1002/jso.24946
|
[14] |
KEMI N, ESKURI M, IKÄLÄINEN J, et al. Tumor budding and prognosis in gastric adenocarcinoma[J]. Am J Surg Pathol, 2019, 43: 229-234. doi: 10.1097/PAS.0000000000001181
|
[15] |
CHRISTOFI T, BARITAKI S, FALZONE L, et al. Current perspectives in cancer immunotherapy[J]. Cancers(Basel), 2019, 11(10): 1472.
|
[16] |
SCHARPING N E, RIVADENEIRA D B, MENK A V, et al. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion[J]. Nat Immunol, 2021, 22(2): 205-215. doi: 10.1038/s41590-020-00834-9
|
[17] |
KEAVER L, HOULIHAN C, O'CALLAGHAN N, et al. Evidence-based nutrition guidelines for cancer survivors in Europe: A call for action[J]. Eur J Clin Nutr, 2021, 29: 1-8.
|